Keck School Faculty

Cynthia L Gong
Cynthia L Gong
Assistant Professor of Research Pediatrics
Los Angeles

United States Valuation of EQ-5D-5L Health States Using an International Protocol Value Health. 2019 Aug; 22(8):931-941. . View in PubMed

Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma Cancers (Basel). 2019 Jul 17; 11(7). . View in PubMed

Behavioral Economics Interventions to Improve Outpatient Antibiotic Prescribing for Acute Respiratory Infections: a Cost-Effectiveness Analysis J Gen Intern Med. 2019 Jun; 34(6):846-854. . View in PubMed

Application of pharmacoeconomics to formulary management in a health system setting Am J Health Syst Pharm. 2019 Feb 21; 76(6):381-386. . View in PubMed

Early onset sepsis calculator-based management of newborns exposed to maternal intrapartum fever: a cost benefit analysis J Perinatol. 2019 04; 39(4):571-580. . View in PubMed

Daratumumab vs pomalidomide for the treatment of relapsed/refractory multiple myeloma: A cost-effectiveness analysis Am J Hematol. 2019 03; 94(3):E68-E70. . View in PubMed

Prescriber preferences for behavioural economics interventions to improve treatment of acute respiratory infections: a discrete choice experiment BMJ Open. 2016 Sep 22; 6(9):e012739. . View in PubMed

Authors' reply to Bosco-Lévy and Salvo BMJ. 2016 Aug 05; 354:i4330. . View in PubMed

Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis BMJ. 2015 Dec 07; 351:h6223. . View in PubMed

Cost-effectiveness analysis of abiraterone and sipuleucel-T in asymptomatic metastatic castration-resistant prostate cancer J Natl Compr Canc Netw. 2014 Oct; 12(10):1417-25. . View in PubMed

Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis PLoS One. 2013; 8(5):e64275. . View in PubMed

Powered by SC CTSI
Go to Top